bpc-157 safety data human FDA's Review Of Peptides Signals A Growing Public Health Challenge Most FDA advisers say peptides

September 19 Product: Johnson & Johnsons Rybrevant Indication: Non-small cell lung cancer Johnson & Johnson racked up its third non-small cell lung cancer (NSCLC) approval for Rybrevant this year as the FDA greenlit the bispecific antibody plus chemotherapy for the second-line treatment of locally advanced or metastatic NSCLC with epidermal growth factor receptor (EGFR) exon 19 deletions or L858R substitution mutations

A.HemmatiS.Yousefi-ManeshH.FekrvandS.ForoutaniL.NassireslamiE.et al (2023)

GLP-1 receptor activation reduces appetite, slows gastric emptying, promotes insulin secretion from pancreatic beta cells, and creates the characteristic feeling of fullness that GLP-1 agonist users report

Hims did a Super Bowl ad where they made claims and they used the literally the GLP-1 brand name of Novo Nordisk drug and violated the law